full
border
#666666
https://www.arboretumvc.com/wp/wp-content/themes/zap-installable/
https://www.arboretumvc.com/wp/
#ffffff
style1

NxThera News

19
Jan

NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy (WAVE®) technology to treat endourological conditions, today announced publication of a recent economic analysis which demonstrates its minimally invasive Rezūm System to be a cost-effective and durable solution in treating benign prostatic hyperplasia (BPH).

Link

0 Comments
03
Jan

NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy (WAVE®) platform technology to treat endourological conditions, announced the three-year outcomes data from the Rezūm II pivotal clinical trial of its minimally invasive Rezūm® System, demonstrating significant, effective and durable lower urinary tract symptom (LUTS) relief, improved quality of life and preserved sexual function for men treated for benign prostatic hyperplasia (BPH). The outcomes were recently published in the January 2018 issue of Urology.

0 Comments
29
Aug

NxThera, Inc., a medical device company pioneering the application of its convective radiofrequency thermal therapy to treat endourological conditions, today announced that new data from the first post-market clinical evaluation of its minimally invasive Rezūm System demonstrated significant, safe and effective urinary symptom relief, improved quality of life and preserved sexual function for men treated for benign prostatic hyperplasia (BPH).

Link

0 Comments
10
May

NxThera, Inc., a medical device company pioneering the application of its convective radiofrequency thermotherapy to treat endourological conditions, today announced the company’s Rezūm System has been used to safely and effectively treat more than 10,000 men suffering from benign prostatic hyperplasia (BPH) across the U.S. and Europe.

Download PDF

0 Comments
06
Apr

NxThera, Inc., a medical device company pioneering the application of its convective radiofrequency thermal technology to treat endourological conditions, today announced the Humana and Aetna health care insurance plans have joined other major insurers to provide coverage of the Rezūm® System for the minimally invasive treatment of benign prostatic hyperplasia (BPH), or enlarged prostate.
Link

0 Comments
03
Dec

NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy (WAVE™) platform technology to treat endourological conditions, today announced completion of a $40M round of financing.

Download PDF

0 Comments
1
2
scrollauto
Loading posts...
link_magnifier
#ffffff
on
loading
off